Arrhythmias & electrophysiology

Association of atrial fibrillation and outcomes in patients undergoing bone marrow transplantation

EuropacePublished Retrospective cohort study

Authors' conclusion

Among patients undergoing HSCT, AF was independently associated with poor in-hospital outcomes, higher LOS, and cost of care.

Study context

Population
Patients aged >50 years undergoing haematopoietic stem cell transplantation (HSCT), US National Inpatient Sample 2016–19
Participants
50,570 weighted hospitalizations
Exposure
Atrial fibrillation (AF) vs no AF in patients undergoing HSCT
  • AFn = 5,820
Outcome
In-hospital outcomes
Methodological detailsNational Inpatient Sample (2016-19), multivariable regression
  • National Inpatient Sample (2016-19)
  • Multivariable regression

Main finding

As reported in the abstract

AF vs No AFAdjusted odds ratio (95% CI)P value
Inpatient mortality
2.75(1.9–3.98)
P < 0.001
Cardiac arrest
2.86(1.55–5.26)
P = 0.001
AKI
1.89(1.6–2.23)
P < 0.001
Acute HF exacerbation
5.01(3.54–7.1)
P < 0.001
Cardiogenic shock
7.73(3.17–18.8)
P < 0.001
Acute respiratory failure
3.24(2.56–4.1)
P < 0.001
Mean length of stay (LOS)
regression coefficient +2.67 (95% CI 1.79–3.55); P < 0.001
Cost of care
regression coefficient +67 529 (95% CI 36 630-98 427); P < 0.001

Observational data: associations, not effects.

Original publication

Association of atrial fibrillation and outcomes in patients undergoing bone marrow transplantation. Europace. Published 19 May 2023. doi:10.1093/europace/euad129

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.